Asphalion & Covid 19
Asphalion contributions to the fight against COVID-19
Asphalion’s teams have both academic research experience and a broad regulatory and technical background in the development and registration of Biologics, including all types of Advanced Therapy Medicinal Products (ATMPs). Our expertise allows us to select the best possible regulatory strategy for your Biological product.
Asphalion can elaborate all regulatory, non-clinical, clinical and CMC documentation required during development, registration and life cycle of Biologics. In addition to this, strategic inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast track, orphan drug designations, preclinical and clinical development plans with minimum time-to-market, among others.
Asphalion’s teams have both academic research experience and a broad regulatory and technical background in the development and registration of Biologics, including all types of Advanced Therapy Medicinal Products (ATMPs). Our expertise allows us to select the best possible regulatory strategy for your Biological product.
Asphalion can elaborate all regulatory, non-clinical, clinical and CMC documentation required during development, registration and life cycle of Biologics. In addition to this, strategic inputs can be given from the very beginning for segmentation/niche indication, conditional approval/fast track, orphan drug designations, preclinical and clinical development plans with minimum time-to-market, among others.
Biologicals Solutions
Ad hoc regulatory advice and strategic consultancy:
Schedule a free meeting!
Discuss your case with our experts and receive a valuable feedback
Share
Why Asphalion?
Thanks to our extensive experience working with Biological products and Biosimilars, we are the ideal partner for defining the best regulatory strategy for our clients´ Biological products.
As part of our modular and flexible support model, we can either assist you with gap analyses of existing documentation or take on the preparation of entire registration dossiers.
We can advise on critical interactions with authorities, such as scientific advice procedures, and can manage them completely for our clients.
Difficult topics, like the extrapolation of indications, are assessed and managed by our senior experts.
We have successfully written full biosimilar dossiers, including all CMC parts, non-clinical and clinical sections, have prepared and attended pre-submission meetings with EMA, and have supported the management of Centralised Procedures and Biologics License Applications, including elaboration of responses to authorities.
Related Resources
Asphalion contributions to the fight against COVID-19
Scientific & Regulatory Affairs Support during development of ATMPs & Biologics
TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.
A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning; we gave our MedTech services
Summer has been officially inaugurated with the CataloniaBio & HealthTech BBQ!!
Services
Memberships & Partnerships
Quality Management System
© Asphalion
Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts.
We will be happy to assist you!
